Skip to main content

Table.9 Outcome according to wbTLG 130 g and TNM stage

From: The utility of the standardized uptake value, metabolic tumor volume and total lesion glycolysis as predictive markers of recurrent breast cancer

  TLG < 130 TLG > 130 p value
TNM stage * wbTLG 130 g cross-tabulation (n = 26)    
TNM stage    
 Low    
  Count 4 0 0.022*
  % of total 15.4% 0.0%  
 High    
  Count 7 15  
  % of total 26.9% 57.7%  
  1. *Significance level (p < 0.05)